Furthermore, in both NC- and miR-125b inhibitor–treated PC-12 cellular AD models, Si-CDK5 attenuated CDK5 expression (Figures 9G,H) and cell apoptosis (Figures 9I,J), whereas it did not affect neurite outgrowth (Figures 9K,L). This evidence concerns the gene CDK5 and Alzheimer disease.